RBV Quarterly: CEO Insights: Dr Gabi Hanna, Lamassu Biotech

01/08/2026

Doctor Gabi Hanna’s journey from Qamishli, in north-west Syria, to leading Lamassu Biotech,

a cutting-edge biopharmaceutical company in the United States, is a study in purpose,

reinvention, and strategic clarity.

Growing up with limited professional pathways, he chose medicine as a way to impact and serve others,

later moving to the United States and spending 15-years in academic medicine before transitioning into

leadership roles within the biotech industry. Today, he combines his clinical background with a

practical, principle-driven approach, bringing together science, strategy, and ethics in one of the world’s

most demanding sectors.

CLICK HERE to read Dr. Gabi Hanna’s full interview with RBV Quarterly.

READ MORE

10/27/2025

Crain’s Cleveland Business: Notable Leaders in Health Care Technology 2025

Health care technology is rapidly transforming how we prevent, diagnose and treat disease, and Northeast Ohio is at the forefront of this evolution. Read Crain's full feature, which includes Lamassu Biotech CEO Dr. Gabi Hanna and Co-Founder Dr. Rabi Hanna.

10/06/2025

Drug Discovery Online: Answering The Call To Develop Novel Drugs For Rare DiseasesDrug Discovery Online:

Faced with a serious diagnosis or an unexpected hospitalization, patients and their families are often left feeling like they’ve been hit with a gut punch. This insecurity is compounded when the diagnosis is some type of rare condition, such as...

06/26/2025

Crain’s Cleveland Business: The U.S. Is Losing Its Biotech Edge

Biotech is one of America’s most critical innovation sectors, but it is facing serious headwinds. Since COVID-19, the industry has been hammered by falling investor confidence, sluggish IPO markets, and rising international competition.  If we do not act to strengthen...